Actively Recruiting
Evaluating Anruikefen Injection for Pain Relief After Total Laparoscopic Radical Distal Gastrectomy in Gastric Cancer Patients
Led by Tianjin Medical University Cancer Institute and Hospital · Updated on 2026-09-22
114
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating Anruikefen, a highly selective kappa receptor agonist that does not easily cross the blood-brain barrier, in people undergoing total laparoscopic distal gastrectomy for gastric cancer. This Phase 2 study aims to confirm the efficacy and safety of Anruikefen for managing postoperative pain. Anruikefen has shown significant pain relief and a lower incidence of postoperative nausea and vomiting in previous trials, supporting its potential advantages over placebo. Participants will be randomly assigned to one of three groups a placebo group receiving normal saline, an Anruikefen intravenous bolus injection group at 1 microgram per kilogram, or an Anruikefen intravenous infusion group at 1.5 micrograms per kilogram. Each treatment is given every 8 hours for a total of six doses following surgery. This study uses a double-blind design to compare these treatments in controlling pain after surgery. During the study, participants will be monitored closely with pain scores assessed at multiple timepoints up to 48 hours after the first dose. Researchers will also measure total opioid use, time to recovery milestones like oral intake and bowel function, inflammatory markers, sleep quality, patient satisfaction, and recovery quality. Safety will be tracked throughout the hospital stay by recording adverse events. The primary outcome is the total consumption of sufentanil via patient-controlled analgesia within 48 hours after the first dose.
CONDITIONS
Brief Title
Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Totally Laparoscopic Radical Distal Gastrectomy
Research Team
B
Bin Ke
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here